Profiel
Harold Jacobi, III is a Director of Deciphera Pharmaceuticals LLC.
He founded Jacobi & Associates and currently serves as a Principal.
Previously, Mr. Jacobi was Vice President of the Massachusetts Trial Lawyers Association for 5 years.
He has corporate law and business litigation experience in banking, real estate, business, and insurance law.
Mr. Jacobi received a BA degree from the University of Virginia in 1967 and a JD degree from Boston University in 1970.
Eerdere bekende functies van Harold Jacobi
| Bedrijven | Functie | Einde |
|---|---|---|
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Directeur/Bestuurslid | - |
Opleiding van Harold Jacobi
| University of Virginia | Undergraduate Degree |
| Boston University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
